Evidences from a Systematic Review and Meta-Analysis Unveil the Role of MiRNA Polymorphisms in the Predisposition to Female Neoplasms
- PMID: 31615040
- PMCID: PMC6834313
- DOI: 10.3390/ijms20205088
Evidences from a Systematic Review and Meta-Analysis Unveil the Role of MiRNA Polymorphisms in the Predisposition to Female Neoplasms
Abstract
Breast (BCa) and gynecological (GCa) cancers constitute a group of female neoplasms that has a worldwide significant contribution to cancer morbidity and mortality. Evidence suggests that polymorphisms influencing miRNA function can provide useful information towards predicting the risk of female neoplasms. Inconsistent findings in the literature should be detected and resolved to facilitate the genetic screening of miRNA polymorphisms, even during childhood or adolescence, and their use as predictors of future malignancies. This study represents a comprehensive systematic review and meta-analysis of the association between miRNA polymorphisms and the risk of female neoplasms. Meta-analysis was performed by pooling odds-ratios (ORs) and generalized ORs while using a random-effects model for 15 miRNA polymorphisms. The results suggest that miR-146a rs2910164 is implicated in the susceptibility to GCa. Moreover, miR-196a2 rs11614913-T had a moderate protective effect against female neoplasms, especially GCa, in Asians but not in Caucasians. MiR-27a rs895819-G might pose a protective effect against BCa among Caucasians. MiR-499 rs3746444-C may slightly increase the risk of female neoplasms, especially BCa. MiR-124 rs531564-G may be associated with a lower risk of female neoplasms. The current evidences do not support the association of the remaining polymorphisms and the risk of female neoplasms.
Keywords: breast neoplasm; cancer; female neoplasm; microRNA; polymorphism; susceptibility.
Conflict of interest statement
The authors declare no conflict of interest.
Figures







References
-
- Fathi E., Farahzadi R., Valipour B., Sanaat Z. Cytokines secreted from bone marrow derived mesenchymal stem cells promote apoptosis and change cell cycle distribution of K562 cell line as clinical agent in cell transplantation. PLoS ONE. 2019;14:e0215678. doi: 10.1371/journal.pone.0215678. - DOI - PMC - PubMed
-
- Gholizadeh-Ghaleh Aziz S., Fathi E., Rahmati-Yamchi M., Akbarzadeh A., Fardyazar Z., Pashaiasl M. An update clinical application of amniotic fluid-derived stem cells (AFSCs) in cancer cell therapy and tissue engineering. Artif. Cells Nanomed. Biotechnol. 2017;45:765–774. doi: 10.1080/21691401.2016.1216857. - DOI - PubMed
-
- PDQ Cancer Genetics Editorial Board . PDQ Cancer Information Summaries. National Cancer Institute (US); Bethesda, MD, USA: 2002. Genetics Editorial Board. Genetics of Breast and Gynecologic Cancers (PDQ(R)): Health Professional Version. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical